<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="163709">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00966979</url>
  </required_header>
  <id_info>
    <org_study_id>66</org_study_id>
    <nct_id>NCT00966979</nct_id>
  </id_info>
  <brief_title>Triathlon速 Partial Knee Replacement (PKR) Outcomes Study</brief_title>
  <acronym>PKR</acronym>
  <official_title>A Prospective, Post-market, Multi-center Study of the Outcomes of the Triathlon速 Partial Knee Resurfacing (PKR) Unicondylar Knee System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stryker Orthopaedics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stryker Orthopaedics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to evaluate the Triathlon速 PKR Knee System and determine whether
      or not the success rate of this device is no worse than the reported success rate of similar
      devices.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Anticipated">June 2027</completion_date>
  <primary_completion_date type="Anticipated">June 2027</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To compare 10 year implant success rate for subjects receiving the Triathlon速 PKR to those rates stated in the literature</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Operating Room (OR) time</measure>
    <time_frame>Intraoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Hospital Stay</measure>
    <time_frame>Hospital Discharge, expected range of 1-3 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amount of Blood Loss</measure>
    <time_frame>Intraoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Range of Motion Improvement at post-surgery visits</measure>
    <time_frame>2 weeks, 6 weeks, 3 months, 1, 2, 5, 7, 10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knee Society Score improvement at post-surgery visits</measure>
    <time_frame>2 weeks, 6 weeks, 3 months, 1, 2, 5, 7, 10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lower Extremity Activity Scale improvement at post-surgery visits</measure>
    <time_frame>2 weeks, 6 weeks, 3 months, 1, 2, 5, 7, 10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Activity Questionnaire improvement at post-surgery visits</measure>
    <time_frame>2 weeks, 6 weeks, 3 months, 1, 2, 5, 7, 10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knee injury and Osteoarthritis Outcome Score (KOOS)</measure>
    <time_frame>2 weeks, 6 weeks, 3 months, 1, 2, 5, 7, 10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-12 Health Survey</measure>
    <time_frame>2 weeks, 6 weeks, 3 months, 1, 2, 5, 7, 10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiographic Data</measure>
    <time_frame>6 weeks, 1, 2, 5, 7, 10 years</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">184</enrollment>
  <condition>Arthroplasty, Replacement, Knee</condition>
  <arm_group>
    <arm_group_label>Triathlon PKR</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>All subjects enrolled will receive the Triathlon PKR device.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Triathlon PKR</intervention_name>
    <description>Triathlon PKR is a unicondylar knee resurfacing system designed to replace a single osteoarthritic compartment of a patient's natural knee.</description>
    <arm_group_label>Triathlon PKR</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The subject is a male or non-pregnant female 21-75 years of age at the time of
             enrollment.

          -  The subject requires a primary cemented unicompartmental knee replacement.

          -  The subject has a diagnosis of osteoarthritis (OA) or posttraumatic arthritis (TA).

          -  The subject has clinically intact cruciate and collateral ligaments and no
             ligamentous instability is present.

          -  The subject has less than 10 degrees of flexion contracture and greater than 90
             degrees of flexion.

          -  The subject's preoperative mechanical alignment is less than 10 degrees of varus and
             10 degrees of valgus.

          -  The subject has signed the IRB approved study specific Informed Patient Consent Form.

          -  The subject is willing and able to comply with postoperative scheduled clinical and
             radiographic evaluations and rehabilitation.

        Exclusion Criteria:

          -  The subject has inflammatory arthritis or avascular necrosis(AVN).

          -  The subject is obese, BMI &gt; 35.

          -  The subject has a history of total or unicompartmental (contralateral compartment
             and/or patellofemoral joint) reconstruction of the affected joint.

          -  The subject has a history of ACL reconstruction.

          -  The subject has had a high distal femoral, or proximal tibial osteotomy.

          -  The subject has a mental, neuromuscular or neurosensory disorder, which would create
             an unacceptable risk of prosthesis instability, prosthesis fixation failure, or
             complications in post-operative care and/or limit the ability to assess the
             performance of the device.

          -  The subject has a systemic or metabolic disorder leading to progressive bone
             deterioration that the surgeon feels would affect the overall outcome of the study.

          -  The subject is immunologically suppressed, or is receiving chronic steroids (&gt;30 days
             duration).

          -  The subject has a known sensitivity to device materials.

          -  The subject's bone stock is compromised by disease and/or infection which cannot
             provide adequate support and/or fixation to the prosthesis.

          -  The subject's bone stock is compromised by a prior implantation which cannot provide
             adequate support and/or fixation to the prosthesis.

          -  The subject has an active or suspected latent infection in or about the knee joint.

          -  The subject is a prisoner.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>R. David Heekin, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Vincent's Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marco Tinius, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Praxisklinik Stollberg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marco Schiraldi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Presidlo Ospedaliero Civile Santi Antonio e Biagio</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bryan Huber, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mansfield Orthopaedics</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fabio Orozco, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rothman Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mathew Phillips, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Orthopaedic Surgery, Kaleida Health, Buffalo General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peter Bonutti, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bonutti Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Soren Toksvig-Larsen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hassleholm Sygehus Ortopaedkirurgisk afd.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Brett Greenky, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Syracuse Orthopedic Specialists</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paul Jacob, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oklahoma Sports Science and Orthopaedics</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lorie Gardner</last_name>
    <phone>201-831-5491</phone>
    <email>Lorie.Gardner@stryker.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Heekin Orthopaedic Institute for Research, Inc.</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Megan Rudelitsch</last_name>
      <phone>904-328-5979</phone>
      <email>mrudelitsch@heekinclinic.com</email>
    </contact>
    <investigator>
      <last_name>R. David Heekin, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bonutti Clinic</name>
      <address>
        <city>Effingham</city>
        <state>Illinois</state>
        <zip>62401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Rothman Institute</name>
      <address>
        <city>Egg Harbor Township</city>
        <state>New Jersey</state>
        <zip>08234</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rex Lutz</last_name>
      <phone>609-677-7015</phone>
      <email>rex.lutz@rothmaninstitute.com</email>
    </contact>
    <investigator>
      <last_name>Fabio Orozco, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Zachary Post, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Orthopaedic Surgery, Kaleida Health, Buffalo General Hospital</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Bayers-Thering</last_name>
      <phone>716-859-1253</phone>
      <email>mbayers-thering@kaleidahealth.org</email>
    </contact>
    <investigator>
      <last_name>Matthew Phillips, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sridhar Rachala, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Syracuse Orthopedic Specialists</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13214</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>AnnMarie Mesick</last_name>
      <phone>315-703-3419</phone>
      <email>AnnMarie.Mesick@sosbones.com</email>
    </contact>
    <investigator>
      <last_name>Brett Greenky, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Seth Greenky, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oklahoma Sports Science and Orthopedics</name>
      <address>
        <city>Edmond</city>
        <state>Oklahoma</state>
        <zip>73103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Mansfield Orthopaedics</name>
      <address>
        <city>Morrisville</city>
        <state>Vermont</state>
        <zip>05661</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leah Morse, MS, PA-C</last_name>
      <phone>802-888-8405</phone>
      <email>lemorse@CHSI.org</email>
    </contact>
    <investigator>
      <last_name>Bryan Huber, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Praxisklinik Stollberg und Arthro. Zentrum GmbH</name>
      <address>
        <city>Stollberg</city>
        <zip>09366</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Presidlo Ospedaliero Civile Santi Antonio e Biagio</name>
      <address>
        <city>Alessandria</city>
        <zip>15100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Hassleholm Sygehus Ortopaedkirurgisk afd.</name>
      <address>
        <city>Esplanadgatan</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Italy</country>
    <country>Sweden</country>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <lastchanged_date>November 29, 2016</lastchanged_date>
  <firstreceived_date>August 25, 2009</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Osteoarthritis, Post-traumatic arthritis</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
